Literature DB >> 24935427

Critical role of matrix metalloprotease-9 in chronic high fat diet-induced cerebral vascular remodelling and increase of ischaemic brain injury in mice†.

Jiao Deng1, Junfeng Zhang2, Chenzhuo Feng2, Lize Xiong3, Zhiyi Zuo4.   

Abstract

AIMS: About one-third of American adults and 20% of teenagers are obese. Obesity and its associated metabolic disturbances including hyperlipidaemia are risk factors for cardiovascular diseases including stroke. They can worsen neurological outcome after stroke. We determined whether obesity and hyperlipidaemia could induce cerebral vascular remodelling via matrix metalloproteases (MMP) and whether this remodelling affected neurological outcome after brain ischaemia. METHODS AND
RESULTS: Six-week-old male CD1, C57BL/6J, and MMP-9(-/-) mice were fed regular diet (RD) or high-fat diet (HFD) for 10 weeks. They were subjected to vascular casting or a 90 min middle cerebral arterial occlusion (MCAO). Mice on HFD were heavier and had higher blood glucose and lipid levels than those on RD. HFD-fed CD1 and C57BL/6J mice had an increased cerebral vascular tortuosity index and decreased inner diameters of the middle cerebral arterial root. HFD increased microvessel density in CD1 mouse cerebral cortex. After MCAO, CD1 and C57BL/6J mice on HFD had a bigger infarct volume, more severe brain oedema and blood-brain barrier damage, higher haemorrhagic transformation rate, greater haemorrhagic volume, and worse neurological function. HFD increased MMP-9 activity in the ischaemic and non-ischaemic brain tissues. Although HFD increased the body weights, blood glucose, and lipid levels in the MMP-9(-/-) mice on a C57BL/6J genetic background, the HFD-induced cerebral vascular remodelling and worsening of neurological outcome did not occur in these mice.
CONCLUSION: HFD induces cerebral vascular remodelling and worsens neurological outcome after transient focal brain ischaemia. MMP-9 activation plays a critical role in these HFD effects. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cerebral vascular remodelling; High fat diet; Ischemic stroke; Matrix metalloprotease; Mouse

Mesh:

Substances:

Year:  2014        PMID: 24935427      PMCID: PMC4200053          DOI: 10.1093/cvr/cvu154

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  42 in total

1.  Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice.

Authors:  Kazuo Yamashiro; Alexandra B Milsom; Johan Duchene; Catherine Panayiotou; Takao Urabe; Nobutaka Hattori; Amrita Ahluwalia
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

2.  Glutamate transporter type 3 knockout reduces brain tolerance to focal brain ischemia in mice.

Authors:  Liaoliao Li; Zhiyi Zuo
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-08       Impact factor: 6.200

3.  Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.

Authors:  Anna Rosell; Arantxa Ortega-Aznar; José Alvarez-Sabín; Israel Fernández-Cadenas; Marc Ribó; Carlos A Molina; Eng H Lo; Joan Montaner
Journal:  Stroke       Date:  2006-05-11       Impact factor: 7.914

4.  Long-term exposure to high fat diet is bad for your brain: exacerbation of focal ischemic brain injury.

Authors:  K D Langdon; J Clarke; D Corbett
Journal:  Neuroscience       Date:  2011-03-22       Impact factor: 3.590

5.  Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling.

Authors:  Mostafa M Elgebaly; Roshini Prakash; Weiguo Li; Safia Ogbi; Maribeth H Johnson; Erin M Mezzetti; Susan C Fagan; Adviye Ergul
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

6.  Prevalence and trends in obesity among US adults, 1999-2008.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Lester R Curtin
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

7.  Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Hiroshi Yatsuya; Aaron R Folsom; Kazumasa Yamagishi; Kari E North; Frederick L Brancati; June Stevens
Journal:  Stroke       Date:  2010-01-21       Impact factor: 7.914

8.  CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.

Authors:  Eunhee Kim; Aaron T Tolhurst; Lu Ye Qin; Xin-Yuan Chen; Maria Febbraio; Sunghee Cho
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

9.  Prevalence of high body mass index in US children and adolescents, 2007-2008.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Molly M Lamb; Katherine M Flegal
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

10.  The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.

Authors:  Bolormaa Vandanmagsar; Yun-Hee Youm; Anthony Ravussin; Jose E Galgani; Krisztian Stadler; Randall L Mynatt; Eric Ravussin; Jacqueline M Stephens; Vishwa Deep Dixit
Journal:  Nat Med       Date:  2011-01-09       Impact factor: 53.440

View more
  30 in total

1.  Obesity and hyperglycemia lead to impaired post-ischemic recovery after permanent ischemia in mice.

Authors:  Jatin Tulsulkar; Shadia E Nada; Brandon D Slotterbeck; Marcia F McInerney; Zahoor A Shah
Journal:  Obesity (Silver Spring)       Date:  2015-12-23       Impact factor: 5.002

2.  Transcriptomic profile analysis of brain microvascular pericytes in spontaneously hypertensive rats by RNA-Seq.

Authors:  Xiaochen Yuan; Qingbin Wu; Xueting Liu; Honggang Zhang; Ruijuan Xiu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Maternal high-fat diet programs cerebrovascular remodeling in adult rat offspring.

Authors:  ChengCheng Lin; XiaoYun Wu; YuLei Zhou; Bei Shao; XiaoTing Niu; WanLi Zhang; YuanShao Lin
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-15       Impact factor: 6.200

4.  Age-Related Upregulation of Carboxyl Terminal Modulator Protein Contributes to the Decreased Brain Ischemic Tolerance in Older Rats.

Authors:  Jun Li; Weiran Shan; Zhiyi Zuo
Journal:  Mol Neurobiol       Date:  2017-12-18       Impact factor: 5.590

5.  Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice.

Authors:  Jiao Deng; Lize Xiong; Zhiyi Zuo
Journal:  J Neurosci Res       Date:  2014-12-09       Impact factor: 4.164

Review 6.  Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.

Authors:  Adviye Ergul; Sherif Hafez; Abdelrahman Fouda; Susan C Fagan
Journal:  Transl Stroke Res       Date:  2016-03-30       Impact factor: 6.829

7.  Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke.

Authors:  Zhongxing Wang; Weiran Shan; Jiangbei Cao; Max Wintermark; Wenqi Huang; Zhiyi Zuo
Journal:  J Neurosci Res       Date:  2017-10-04       Impact factor: 4.164

Review 8.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

Review 9.  Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.

Authors:  Eduardo Candelario-Jalil; Surojit Paul
Journal:  Exp Neurol       Date:  2020-10-07       Impact factor: 5.330

10.  Obesity Drives Delayed Infarct Expansion, Inflammation, and Distinct Gene Networks in a Mouse Stroke Model.

Authors:  Todd C Peterson; Kendra J Lechtenberg; Brian D Piening; Tawaun A Lucas; Eric Wei; Hassan Chaib; Alexa K Dowdell; Michael Snyder; Marion S Buckwalter
Journal:  Transl Stroke Res       Date:  2020-06-25       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.